Literature DB >> 2754753

Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy.

L L Cregler.   

Abstract

The incidence of hypertrophic cardiomyopathy progressing to dilated cardiomyopathy is rare. A patient diagnosed at age 22 and followed for 24 years who progressed to a dilated cardiomyopathy with severe congestive heart failure is reported. Left ventricular dilatation in hypertrophic cardiomyopathy may be due to a complication of surgery, beta-blocker therapy, or myocardial infarction. It may also represent the natural history in a subset of patients with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Year:  1989        PMID: 2754753      PMCID: PMC2625919     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

Authors:  P Spirito; B J Maron; R O Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

2.  Progression of hypertrophic cardiomyopathy to congestive cardiomyopathy: case report.

Authors:  W Brett; P W Brandt; A R Bierre; A H Roche
Journal:  N Z Med J       Date:  1985-11-27

Review 3.  Treatment of the cardiomyopathies.

Authors:  J F Goodwin
Journal:  Am J Cardiol       Date:  1973-09-07       Impact factor: 2.778

4.  The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study.

Authors:  W J McKenna; M Borggrefe; D England; J Deanfield; C M Oakley; J F Goodwin
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

5.  Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy.

Authors:  R O Cannon; W H Schenke; B J Maron; C M Tracy; M B Leon; J E Brush; D R Rosing; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

6.  Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries.

Authors:  B J Maron; S E Epstein; W C Roberts
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

7.  Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy.

Authors:  F J ten Cate; J Roelandt
Journal:  Am Heart J       Date:  1979-06       Impact factor: 4.749

Review 8.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.

Authors:  E D Wigle; Z Sasson; M A Henderson; T D Ruddy; J Fulop; H Rakowski; W G Williams
Journal:  Prog Cardiovasc Dis       Date:  1985 Jul-Aug       Impact factor: 8.194

9.  Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy.

Authors:  M Funakoshi; M Imamura; J Sasaki; M Fujino; T Kawano; Y Sasaki; Y Nakashima; T Motooka; K Fukuda; M Imagawa
Journal:  Jpn Heart J       Date:  1984-09

10.  Prognosis in hypertrophic cardiomyopathy.

Authors:  Y Koga; K Itaya; H Toshima
Journal:  Am Heart J       Date:  1984-08       Impact factor: 4.749

View more
  1 in total

Review 1.  The cell biology of disease: cellular mechanisms of cardiomyopathy.

Authors:  Pamela A Harvey; Leslie A Leinwand
Journal:  J Cell Biol       Date:  2011-08-08       Impact factor: 10.539

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.